Pacira BioSciences, Inc. Common Stock (PCRX) is a publicly traded Healthcare sector company. As of July 22, 2026, PCRX trades at $25.77 with a market cap of $997.47M and a P/E ratio of 159.94. PCRX moved +1.66% today. Year to date, PCRX is -0.39%; over the trailing twelve months it is +16.28%. Its 52-week range spans $16.41 to $27.64. Analyst consensus is buy with an average price target of $29.75. Rallies surfaces PCRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Pacira BioSciences, Inc. Common Stock (PCRX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PCRX moved +1.66% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $25.77 |
| Market Cap | $997.47M |
| P/E Ratio | 159.94 |
| EPS | $0.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.64 |
| 52-Week Low | $16.41 |
| Volume | 311.77K |
| Avg Volume | 0 |
| Revenue (TTM) | $726.41M |
| Net Income | $7.03M |
| Gross Margin | 79.39% |
5 analysts cover PCRX: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $29.75.